Trial
NCT05488626
Daily Adaptive Radiation Therapy: An Individualized Approach for Stage III Lung Cancer
UnknownWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Varian, a Siemens Healthineers Company
Collaborators
—
Condition
Stage III Non-small Cell Lung Cancer
Intervention
Adaptive Radiotherapy
Why stopped
Shifting patterns of care for the target population.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-05